ZANUBRUTINIB

zanubrutinib 80 mg capsule, 120

ZANUBRUTINIB (12891L)

zanubrutinib 80 mg capsule, 120
12891L
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Mantle cell lymphoma
Treatment phase: Initial treatment

Restriction

Indication: Mantle cell lymphoma
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 120 # of repeats: 5 DPMQ: $7,932.89 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Brukinsa